A Study to Evaluate the Efficacy, Safety and Immunogenicity of MTBVAC in Adolescents and Adults Living in a TB Endemic Region.

31 Mar 20264 min read0 viewsINTERVENTIONAL Trial

GIST

RECRUITING · INTERVENTIONAL · PREVENTION study · Tuberculosis (TB) · Phase 2 · Enrollment 5500 · Sponsor: International AIDS Vaccine Initiative

Clinical Editorial

Summary

ClinicalTrials.gov published a clinical update in Infectious Disease on 31 Mar 2026. The item focuses on A Study to Evaluate the Efficacy, Safety and Immunogenicity of MTBVAC in Adolescents and Adults Living in a TB Endemic Region. Open the detail page to review the full original feed content.